Gilead Sciences's market cap is currently ―. The company's EPS TTM is $4.503; its P/E ratio is 15.04; and it has a dividend yield of 4.44%. Gilead Sciences is scheduled to report earnings on April 25, 2024, and the estimated EPS forecast is $1.58. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 7.05B	$ 6.56B	$ 6.31B	$ 7.39B	$ 7.04B
Gross Profit	$ 5.49B	$ 5.16B	$ 4.95B	$ 5.99B	$ 5.65B
EBIT	$ 2.55B	$ 1.82B	$ 1.53B	$ 2.26B	$ 2.66B
EBITDA	$ 3.23B	$ 2.50B	$ 2.17B	$ 2.79B	$ 3.19B
Net Income Common Stockholders	$ 2.18B	$ 1.04B	$ 1.01B	$ 1.64B	$ 1.79B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.16B	$ 6.67B	$ 5.87B	$ 6.38B	$ 5.66B
Total Assets	$ 62.37B	$ 62.34B	$ 61.88B	$ 63.17B	$ 62.56B
Total Debt	$ 24.98B	$ 25.25B	$ 25.24B	$ 25.23B	$ 25.22B
Net Debt	$ 23.82B	$ 18.58B	$ 19.37B	$ 18.84B	$ 19.56B
Total Liabilities	$ 40.13B	$ 41.24B	$ 40.94B	$ 41.96B	$ 41.50B
Stockholders Equity	$ 22.31B	$ 21.16B	$ 21.00B	$ 21.24B	$ 21.08B
Cash Flow	-
Free Cash Flow	$ 2.35B	$ 1.48B	$ 1.64B	$ 2.39B	$ 2.71B
Operating Cash Flow	$ 2.47B	$ 1.62B	$ 1.75B	$ 2.57B	$ 2.86B
Investing Cash Flow	$ -229.00M	$ -483.00M	$ -826.00M	$ -375.00M	$ -713.00M
Financing Cash Flow	$ -2.24B	$ -383.00M	$ -1.41B	$ -1.55B	$ -2.12B

Currency in USD

Gilead Sciences Earnings and Revenue History

Income Statement >

Gilead Sciences Debt to Assets

Balance Sheet >

Gilead Sciences Cash Flow

Cash Flow >

Gilead Sciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing